Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Price

Showing results (931-940 of 1,241) with videos related to

Pageof 125
Sort By:
European Journal of Medicinal Chemistry|January 5, 2023
Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potentialPeter J Slavish, Maxime G Cuypers, Mary Ashley Rimmer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2020
Development and Preliminary Validation of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO)Saied Ghadersohi, Caroline P E Price, Sally E Jensen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 4, 2020
Responsiveness and Convergent Validity of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO)Saied Ghadersohi, Caroline P E Price, Jennifer L Beaumont, et al.
International Forum of Allergy & Rhinology|September 2, 2017
A prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polypsAva R Weibman, Julia He Huang, Whitney W Stevens, et al.
Rheumatology (Oxford, England)|December 28, 2018
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseasesSonali Wijetilleka, David R Jayne, Chetan Mukhtyar, et al.
The Lancet. Haematology|May 8, 2018
Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohortBrian M Feldman, Georges E Rivard, Paul Babyn, et al.
Implementation Science Communications|March 8, 2022
A stakeholder-driven method for selecting implementation strategies: a case example of pediatric hypertension clinical practice guideline implementationAshley A Knapp, Allison J Carroll, Nivedita Mohanty, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 7, 2022
Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trialCaroline P E Price, Amina Guo, Whitney W Stevens, et al.
International Forum of Allergy & Rhinology|April 1, 2022
CRS-PRO and SNOT-22 correlations with type 2 inflammatory mediators in chronic rhinosinusitisSamuel D Racette, Alexander L Schneider, Meera Ganesh, et al.
Cancer Research|December 17, 2005
High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptorNobukazu Fujimoto, Marie Wislez, Jie Zhang, et al.
Pageof 125

Showing results (931-940 of 1,241) with videos related to

Sort By:
Pageof 125
European Journal of Medicinal Chemistry|January 5, 2023
Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potentialPeter J Slavish, Maxime G Cuypers, Mary Ashley Rimmer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2020
Development and Preliminary Validation of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO)Saied Ghadersohi, Caroline P E Price, Sally E Jensen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 4, 2020
Responsiveness and Convergent Validity of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO)Saied Ghadersohi, Caroline P E Price, Jennifer L Beaumont, et al.
International Forum of Allergy & Rhinology|September 2, 2017
A prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polypsAva R Weibman, Julia He Huang, Whitney W Stevens, et al.
Rheumatology (Oxford, England)|December 28, 2018
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseasesSonali Wijetilleka, David R Jayne, Chetan Mukhtyar, et al.
The Lancet. Haematology|May 8, 2018
Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohortBrian M Feldman, Georges E Rivard, Paul Babyn, et al.
Implementation Science Communications|March 8, 2022
A stakeholder-driven method for selecting implementation strategies: a case example of pediatric hypertension clinical practice guideline implementationAshley A Knapp, Allison J Carroll, Nivedita Mohanty, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 7, 2022
Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trialCaroline P E Price, Amina Guo, Whitney W Stevens, et al.
International Forum of Allergy & Rhinology|April 1, 2022
CRS-PRO and SNOT-22 correlations with type 2 inflammatory mediators in chronic rhinosinusitisSamuel D Racette, Alexander L Schneider, Meera Ganesh, et al.
Cancer Research|December 17, 2005
High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptorNobukazu Fujimoto, Marie Wislez, Jie Zhang, et al.
Pageof 125